Form 8-K - Current report:
SEC Accession No. 0001193125-15-256459
Filing Date
2015-07-20
Accepted
2015-07-20 06:08:39
Documents
4
Period of Report
2015-07-17
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d47708d8k.htm 8-K 21055
2 EX-2.1 d47708dex21.htm EX-2.1 405448
3 EX-2.2 d47708dex22.htm EX-2.2 379103
4 EX-99.1 d47708dex991.htm EX-99.1 7027
  Complete submission text file 0001193125-15-256459.txt   814026
Mailing Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 15995034
SIC: 3826 Laboratory Analytical Instruments